5961 - 5970 of 9035 Results
Title
Year
- An MDS Evidence‐Based Review on Treatments for Huntington's Disease2022RESTRICTEDTitle: An MDS Evidence‐Based Review on Treatments for Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1566End Page: 1567Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29059Citation Count: 1
- Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?2022RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 19
-
OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01170-2/pdfCitation Count: 3
- Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort2024OPENTitle: Advancing Parkinson’s Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) CohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 7Start Page: 1481End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240213Best OA location URL: https://doi.org/10.3233/jpd-240213Citation Count: 9
-
OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 3
-
OPENTitle: Brain-first forms of Parkinson's disease are over-represented in patients with non-responsive resting tremorJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 201Issue #:Start Page: 106691End Page: 106691Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2024.106691Best OA location URL: https://doi.org/10.1016/j.nbd.2024.106691Citation Count: 1
-
OPENTitle: Stearoyl-CoA desaturase inhibition normalizes brain lipid saturation, α-synuclein homeostasis, and motor function in mutant Gba1-Parkinson miceJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 10Issue #: 13Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.188413Best OA location URL: http://insight.jci.org/articles/view/188413/files/pdfCitation Count: 4
-
OPENTitle: Regulation of LRRK2 activity by metabolic stress and heavy metal exposureJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1863Issue #:Start Page: 149785End Page: 149785Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2025.149785Best OA location URL: https://doi.org/10.1016/j.brainres.2025.149785Citation Count: 0
-
OPENTitle: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegenerationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 382Issue #:Start Page: 114959End Page: 114959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114959Citation Count: 8
-
OPENTitle: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01130-1/pdfCitation Count: 0